Dr. Singh's laboratory pioneers research on the pathogenesis of drug-resistant fungal pathogens and the development of antimicrobials, vaccines and immunotherapies, targeting WHO priority fungal pathogens. Dr. Singh employs cutting-edge bioinformatics, immuno-proteomics, molecular biology techniques, and a range of animal models to achieve these goals.